Quantcast

Latest placebo Stories

2014-01-30 08:31:26

CRANBURY, N.J., Jan. 30, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that data from a 12-week placebo-controlled dose-ranging study using self-administered subcutaneous bremelanotide for the treatment of female sexual dysfunctions will be presented at the 16(th) Congress of the European Society for Sexual Medicine in Istanbul, Turkey on Friday, January 31, 2014 at 3:25 PM local time. Dr. Michael L. Krychman from Southern California Center for...

2014-01-29 16:28:39

Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 29, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the completion of the randomized, double-blind placebo-controlled Phase 2 study of KB003, its anti-GM-CSF monoclonal antibody (mAb), in patients with severe asthma. While the study showed that KB003 was generally safe and well tolerated, it did not meet its primary clinical endpoint of improvement in FEV(1) (a measurement of pulmonary...

2014-01-24 23:21:39

Natreon, Inc, and NutraGenesis, LLC are pleased to announce a new study published on Sensoril® demonstrates Sensoril’s ability to significantly improve cognitive and psychomotor performance. Brattleboro, VT (PRWEB) January 24, 2014 Natreon, Inc, and NutraGenesis, LLC are pleased to announce publication of a new study on Sensoril® which demonstrated Sensoril’s ability to significantly improve cognitive and psychomotor performance during simple reaction, choice discrimination,...

2014-01-23 16:25:23

MALVERN, Pa. and RALEIGH, N.C., Jan. 23, 2014 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP), and BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today positive top-line results from its pivotal Phase 3 efficacy study of BEMA buprenorphine in opioid- "naive" subjects. BEMA buprenorphine is being developed for the treatment of moderate to severe chronic pain in patients requiring around-the-clock opioid therapy for...

2014-01-23 04:21:19

LONDON, January 23, 2014 /PRNewswire/ -- The recent BBC report on January 3rd revealed shocking figures of obesity quadrupling to nearly one billion in the developing world since the 1980s. 64% of adults are now classified as overweight or obese in the UK. With high levels of cheap convenience food available, and the increasing numbers of overweight Brits on the increase, Weightmasters have revealed successful results from clinical trials on their Natural Appetite Suppressant,...

Caffeine Enhances Memory For Up To 24 Hours
2014-01-13 04:46:47

[ Watch the Video: Memory Enhancement From Coffee Consumption ] redOrbit Staff & Wire Reports - Your Universe Online While caffeinated beverages such as coffee and tea are commonly consumed by people looking for an early morning energy boost, new research appearing in the journal Nature Neuroscience suggests that they could also serve as a memory enhancer. Michael Yassa, assistant professor of psychological and brain sciences, and his colleagues report in their study that...

Placebo Effect Enhances Migraine Drug
2014-01-09 08:33:52

redOrbit Staff & Wire Reports - Your Universe Online A new study of migraine sufferers is the latest to demonstrate the remarkable power of the placebo effect, finding that what a doctor tells you when prescribing medicine can influence your body's response to it. The study, published Wednesday in the journal Science Translational Medicine, compared the effects of the common migraine drug Maxalt (rizatriptan) to an inactive placebo (sugar pill) in 66 sufferers of chronic migraine...

2014-01-07 04:21:03

LONDON, January 7, 2014 /PRNewswire/ -- ~ ST10 strongly demonstrates potential to be (1) the only effective oral treatment for ferrous intolerant IDA patients and (2) an effective alternative to intravenous iron treatment ~ Shield Therapeutics (Shield), an independent specialty pharmaceutical company focused on the development of mineral-derived hospital pharmaceuticals, today announces strongly positive top-line data from...

2014-01-06 16:27:45

Plans to submit end of phase II meeting request to FDA SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that NBI-98854, a small molecule VMAT2 inhibitor, showed a statistically significant and clinically meaningful reduction in tardive dyskinesia symptoms in the Phase IIb Kinect 2 study. The pre-specified primary endpoint was the change-from-baseline in the Abnormal Involuntary Movement Scale (AIMS) at Week 6 as assessed by central...

Vitamin E Curbs Alzheimer's Symptoms
2014-01-01 14:36:42

Brett Smith for redOrbit.com - Your Universe Online A new study published in The Journal of the American Medical Association on Wednesday has indicated that taking vitamin E supplements during the early stages of Alzheimer’s can slow the progression of cognitive decline symptoms. Study researchers said they found the supplement allowed patients' to maintain their ability to perform basic tasks by an average of about six months. "It will be very interesting to see to what extent...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related